Vicarious Surgical (NYSE:RBOT) announced today that it successfully completed an in-vivo porcine lab as it advances its ...

The December in-vivo lab builds on Vicarious Surgical's disciplined, specification-driven development approach and reflects the company's focus on minimizing technical risk through iterative testing, ...

Vicarious Surgical said Wednesday that it will outsource some components of its robot’s development to lower spending as it prepares the system for a clinical trial and regulatory submission. The ...

Under the agreement, the engineering partner will be responsible for a significant portion of the software development for the Vicarious robotic system.

WALTHAM, Mass., October 30, 2025--(BUSINESS WIRE)--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to ...

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient ...

Elon Musk and Mark Zuckerberg might not be able to agree about much when it comes to AI these days, but the pair do seem to see the same potential in Vicarious, a startup applying unsupervised ...